JKT · UNVR.JK
PT Unilever Indonesia Tbk
IDR 1,390-IDR 10 (-0.71%)
PT Unilever Indonesia Tbk’s quoted price sits in the lower half of its reported 52-week range, 50.53% below the high.
Loading market information…
JKT · EURO.JK · IDR
Stock price, dividends
Quote as of Oct 30, 2026, 08:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · IDR. Historical prices are not a forecast.
PT Estee Gold Feet Tbk’s quoted price sits in the lower half of its reported 52-week range, 78.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
PT Estee Gold Feet Tbk’s forward annual dividend is IDR 1 per share, paid annual. The forward yield is 0.1% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
PT Estee Gold Feet Tbk specializes in the production and distribution of a diverse array of cosmetic items and essential household health and hygiene products. Its cosmetics portfolio features personal care essentials such as deodorants, various fragrances including eau de toilette, eau de parfum, eau de cologne, body perfumes, and perfume sprays, as well as lotions and hair styling solutions. For domestic use, the company supplies disinfectants, specialized antiseptics for helmets and jackets, air and car fresheners, and hand sanitizers. Furthermore, PT Estee Gold Feet Tbk extends its services to include contract manufacturing (tolling) for aerosol and liquid formulations utilized in cosmetics, household goods, and automotive chemical applications. The company, established in 1978, operates from its headquarters located in Jakarta Utara, Indonesia.
Latest available per-share figures in IDR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:05 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
IDR 1,390-IDR 10 (-0.71%)
PT Unilever Indonesia Tbk’s quoted price sits in the lower half of its reported 52-week range, 50.53% below the high.
IDR 985-IDR 70 (-6.64%)
PT Victoria Care Indonesia Tbk’s quoted price sits in the upper half of its reported 52-week range, 31.83% below the high.
IDR 1,200+IDR 10 (+0.84%)
PT Duta Intidaya Tbk’s quoted price sits in the lower half of its reported 52-week range, 37.66% below the high.
IDR 1,300-IDR 10 (-0.76%)
PT Kino Indonesia Tbk’s quoted price sits in the upper half of its reported 52-week range, 12.75% below the high.
IDR 1,570IDR 0 (0.0%)
PT Darya-Varia Laboratoria Tbk’s quoted price sits in the upper half of its reported 52-week range, 7.37% below the high.
IDR 408-IDR 26 (-5.99%)
PT Uni-Charm Indonesia Tbk’s quoted price sits in the lower half of its reported 52-week range, 27.14% below the high.
IDR 2,470+IDR 20 (+0.82%)
PT. Mandom Indonesia Tbk’s quoted price sits in the lower half of its reported 52-week range, 34.83% below the high.
IDR 486+IDR 28 (+6.11%)
PT Multi Indocitra Tbk’s quoted price sits in the lower half of its reported 52-week range, 33.42% below the high.
